Intellia Therapeutics, Inc. (NTLA)

13.82 +0.21 (+1.54%) USD  |  NASDAQ  |  Mar 04, 16:00
13.84 +0.02 (+0.18%) After-Hours: 20:00
More

Intellia Therapeutics Total Expenses (% of Annual Revenues)

Total Expenses (% of Annual Revenues) Chart

View Total Expenses (% of Annual Revenues) for NTLA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Expenses (% of Annual Revenues) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Total Expenses (% of Annual Revenues) Range, Past 5 Years

View Total Expenses (% of Annual Revenues) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Expenses (% of Annual Revenues) Benchmarks

View Total Expenses (% of Annual Revenues) Benchmarks
Start Trial
Beam Therapeutics, Inc. Upgrade
Personalis, Inc. Upgrade
Recursion Pharmaceuticals, Inc. Upgrade
Pacific Biosciences of California, Inc. Upgrade
Twist Bioscience Corp. Upgrade